Arul Marimuthu

Title: Innovations of Arul Marimuthu in Recombinant Human Insulin Crystallization

Introduction

Arul Marimuthu is a notable inventor based in Thanjavur, India. He has made significant contributions to the field of biotechnology, particularly in the crystallization of recombinant human insulin. His innovative methods have the potential to enhance the efficiency and consistency of insulin production.

Latest Patents

Arul Marimuthu holds a patent for the "Preparative crystallization of recombinant human insulin." This invention discloses a method for crystallizing recombinant human insulin at both lab and manufacturing scales. The process involves the use of a mixture of zinc chloride and sodium chloride, along with a higher concentration of organic solvent (IPA-19 to 25 million). The pH is adjusted to 5.0 at a faster rate of ≤5 minutes. Additionally, the method includes procedures that reduce settling time and alter holding temperature to facilitate consistent protein crystal formation between 15 μm-30 μm, thereby increasing the robustness of the process.

Career Highlights

Arul Marimuthu is currently associated with Biocon Limited, a leading biopharmaceutical company. His work focuses on developing innovative solutions in the field of insulin production, which is crucial for diabetes management. His expertise and dedication have positioned him as a valuable asset in the biotechnology sector.

Collaborations

Arul has collaborated with several professionals in his field, including Vibhava Shukla and Sai Srikar Kandukuri. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Arul Marimuthu's contributions to the crystallization of recombinant human insulin exemplify the impact of innovative thinking in biotechnology. His patent and ongoing work at Biocon Limited highlight the importance of advancements in medical science.